Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. AGIO
AGIO logo

AGIO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AGIO News

Agios Pharmaceuticals Shares Rise 11.2% Following Strong Earnings Report

May 02 2026Fool

Agios Pharmaceuticals Shares Surge 13.11% After Earnings Report

Apr 29 2026Fool

Agios Pharmaceuticals Reports $21 Million Revenue in Q1

Apr 29 2026NASDAQ.COM

Agios Pharmaceuticals Q1 2026 Earnings Call Highlights

Apr 29 2026seekingalpha

Agios Pharmaceuticals Q1 2026 Earnings Highlights

Apr 29 2026seekingalpha

Agios Pharmaceuticals Reports Strong Q1 2026 Financial Results and Strategic Updates

Apr 29 2026Newsfilter

Agios Pharmaceuticals to Announce Q1 Earnings on April 29

Apr 28 2026seekingalpha

Agios Pharmaceuticals Stock Hits Oversold Territory

Apr 27 2026NASDAQ.COM

Agios Pharmaceuticals Shares Plunge 26.8% Following Novo Nordisk Drug Results

Apr 24 2026Fool

AGIOS PHARMACEUTICALS INC: H.C. Wainwright Lowers Price Target from $65 to $50

Apr 21 2026moomoo

Novo's Successful Trial Impacts Agios Stock Performance

Apr 20 2026stocktwits

Agios Pharmaceuticals Shares Plunge 23% Amid Competitive Drug News

Apr 20 2026Fool

Agios Pharmaceuticals Under Investigation Following Phase 3 Trial Results, Stock Plummets

Apr 01 2026Newsfilter

Health Care Stocks Rise 2% Boosting Market

Mar 31 2026Yahoo Finance

Agios Pharmaceuticals Accelerates FDA Approval for Mitapivat

Mar 31 2026Fool

Agios Executive Sells Shares for Tax Obligation

Mar 31 2026Fool